发明名称 Chromatographic process for resolving two enantiomers of tetralone intermediate of antidepressant sertraline, using enantioselective stationary phase and eluting with carbon dioxide
摘要 Chromatographic process for resolving a mixture of the two enantiomers of the tetralone intermediate (II) formed during the synthesis of sertraline (I), eluting with a mixture containing carbon dioxide in the supercritical, critical, or subcritical state, the system percolating through an enantioselective stationary phase containing macrocyclic heterotopic coreceptors (MHCR). Chromatographic process for resolving a mixture of the two enantiomers of the tetralone intermediate of formula (II) formed during the synthesis of sertraline of formula (I), eluting with a mixture containing carbon dioxide in the supercritical, critical, or subcritical state, the system percolating through an enantioselective stationary phase containing macrocyclic heterotopic coreceptors (MHCR).
申请公布号 FR2810978(A1) 申请公布日期 2002.01.04
申请号 FR20000008444 申请日期 2000.06.29
申请人 CHIRALSEP 发明人
分类号 B01D15/18;B01D15/38;B01D15/40;C07C45/78;C07C45/79;C07C49/697;(IPC1-7):C07C45/79;C07B63/00 主分类号 B01D15/18
代理机构 代理人
主权项
地址